综合研究结果和讨论部分，Myosin 5a 在膀胱运动神经调节中起着至关重要的作用。在 STZ 诱导的糖尿病大鼠中，Myosin 5a 的异常表达影响了膀胱神经传递，加剧了膀胱过度活动。这一发现为糖尿病引发的 OAB 的临床治疗提供了重要的病理生理学基础，也为开发针对 Myosin 5a 的新型药物提供了更完善的研究思路和方法。不过，研究也存在一些局限性，比如未明确 Myosin 5a ...

Interactive Tool Harnesses Real-World Data to Visualize Burden of Disease in HCM and Advance Equitable Access to CareSOUTH SAN FRANCISCO, Calif., ...

Our skin and mucous membranes are protected by epithelial cells. This “barrier” tissue performs its function thanks to ...

Late Breaker Oral Presentation to Include New Data from Cohort 1 of the MyPEAK™-1 Phase 1b/2 Clinical Trial of TN-201SOUTH ...

New Analyses Related to Aficamten Expand on its Metabolism Pathways,Treatment Effect Associated with Combination Therapy with ...

JUPITER, Fla., Feb. 26, 2025 /PRNewswire/ -- Myosin Therapeutics, Inc., a biotechnology company developing novel therapies for cancer and neurological disorders, has closed its second seed funding ...

STORY HIGHLIGHTS Myosin Therapeutics secured $3 million in seed funding. Funding will initiate clinical trials for brain cancer and addiction. MT-125 and MT-110 drugs target glioblastoma and ...

Cytokinetics has a strong cash runway but faces risks from its Royalty Pharma deal. Read more on what's ahead for this ...

Cytokinetics is now rapidly moving into commercialization efforts with Aficamten. Read more to see why I rate CYTK stock a ...

UMass Lowell Recognized as Top Research Institution with R1 Classification Read More ⁠ ...